DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development

Diffuse lower WHO grade II and III gliomas (LGG) are slowly progressing brain tumors, many of which eventually transform into a more aggressive type. LGG is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the heterogeneity of the DNA methylome, its fu...

Full description

Saved in:
Bibliographic Details
Main Authors: Binder, Hans (Author) , Jones, David T. W. (Author) , Pfister, Stefan (Author) , Wick, Wolfgang (Author)
Format: Article (Journal)
Language:English
Published: 25 April 2019
In: Acta Neuropathologica Communications
Year: 2019, Volume: 7, Pages: 1-18
ISSN:2051-5960
DOI:10.1186/s40478-019-0704-8
Online Access:Verlag, Volltext: https://doi.org/10.1186/s40478-019-0704-8
Get full text
Author Notes:H. Binder, E. Willscher, H. Loeffler-Wirth, L. Hopp, D.T.W. Jones, S.M. Pfister, M. Kreuz, D. Gramatzki, E. Fortenbacher, B. Hentschel, M. Tatagiba, U. Herrlinger, H. Vatter, J. Matschke, M. Westphal, D. Krex, G. Schackert, J.C. Tonn, U. Schlegel, H.-J. Steiger, W. Wick, R. Weber, M. Weller, and M. Loeffler
Description
Summary:Diffuse lower WHO grade II and III gliomas (LGG) are slowly progressing brain tumors, many of which eventually transform into a more aggressive type. LGG is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the heterogeneity of the DNA methylome, its function in tumor biology, coupling with the transcriptome and tumor microenvironment and its possible impact for tumor development.
Item Description:Gesehen am 18.07.2019
Physical Description:Online Resource
ISSN:2051-5960
DOI:10.1186/s40478-019-0704-8